Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 89 publications
The tumor microenvironment of medulloblastoma: from emerging biological insights to novel therapeutic targeting.
Journal: Frontiers in oncology
Published: February 17, 2026
Pediatric Brain Tumor Consortium phase 1 study of CD40 agonist sotigalimab in pediatric and young adult patients with recurrent CNS tumors and newly-diagnosed DIPG.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 13, 2026
First-in-child phase I trial of p-STAT3 inhibitor WP1066 in pediatric brain tumor patients.
Journal: JCI insight
Published: December 11, 2025
ONC206 demonstrates potent anti-tumorigenic activity and is a potential novel therapeutic strategy for high-risk medulloblastoma.
Journal: bioRxiv : the preprint server for biology
Published: November 19, 2025
ONC206 demonstrates potent anti-tumorigenic activity and is a potential novel therapeutic strategy for high-risk medulloblastoma.
Journal: Neuro-oncology
Published: September 18, 2025
ONC206 demonstrates potent antitumorigenic activity and is a potential novel therapeutic strategy for high-risk medulloblastoma.
Journal: Neuro-oncology
Published: September 18, 2025
Data-Driven Feedback Identifies Focused Ultrasound Exposure Regimens for Improved Nanotheranostic Targeting of the Brain.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: September 11, 2025
Data-driven feedback augments ultrasound nanotheranostics in brain tumors.
Journal: bioRxiv : the preprint server for biology
Published: July 14, 2025
First-in-child phase I trial of p-STAT3 inhibitor WP1066 in pediatric brain tumor patients.
Journal: JCI insight
Published: April 24, 2025
Device-assisted strategies for drug delivery across the blood-brain barrier to treat glioblastoma.
Journal: Communications materials
Published: November 21, 2024
BRAF inhibitor monotherapy in BRAFV600E-mutated pediatric low-grade glioma: a single center's experience.
Journal: Frontiers in oncology
Published: October 10, 2024
Medulloblastoma Spatial Transcriptomics Reveals Tumor Microenvironment Heterogeneity with High-Density Progenitor Cell Regions Correlating with High-Risk Disease.
Journal: bioRxiv : the preprint server for biology
Published: July 09, 2024
Last Updated: 09/26/2026